Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Drug Resistance

  Free Subscription


11 Antimicrob Agents Chemother
14 Int J Antimicrob Agents
9 J Antimicrob Chemother
1 PLoS Genet
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antimicrob Agents Chemother

  1. PETRAITIS V, Petraitiene R, Kavaliauskas P, Naing E, et al
    Development of rabbit models of ventilator-associated bacterial pneumonia produced by carbapenem-resistant Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2024 Apr 30:e0020524. doi: 10.1128/aac.00205.
    PubMed         Abstract available

  2. SUN L, Zhuang H, Chen M, Chen Y, et al
    Vancomycin heteroresistance caused by unstable tandem amplifications of the vanM gene cluster on linear conjugative plasmids in a clinical Enterococcus faecium.
    Antimicrob Agents Chemother. 2024 Mar 20:e0115923. doi: 10.1128/aac.01159.
    PubMed         Abstract available

  3. SUZUKI D, Sakurai A, Wakuda M, Suzuki M, et al
    Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2024;68:e0167223.
    PubMed         Abstract available

  4. XIA L, Li Y, Wang Y, Zhou H, et al
    Quorum-sensing regulation of phenazine production heightens Pseudomonas aeruginosa resistance to ciprofloxacin.
    Antimicrob Agents Chemother. 2024;68:e0011824.
    PubMed         Abstract available

  5. CASTANHEIRA M, Kimbrough JH, Lindley J, Doyle TB, et al
    In vitro development of resistance against antipseudomonal agents: comparison of novel beta-lactam/beta-lactamase inhibitor combinations and other beta-lactam agents.
    Antimicrob Agents Chemother. 2024;68:e0136323.
    PubMed         Abstract available

  6. GHOSH S, Orman MA
    Exploring the links between SOS response, mutagenesis, and resistance during the recovery period.
    Antimicrob Agents Chemother. 2024;68:e0146223.
    PubMed         Abstract available

  7. ISHII M, Yamada T, Ishikawa K, Ichinose K, et al
    The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum.
    Antimicrob Agents Chemother. 2024;68:e0160923.
    PubMed         Abstract available

  8. MILLER AA, Moussa SH, McLeod SM
    Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK).
    Antimicrob Agents Chemother. 2024;68:e0169823.
    PubMed         Abstract available

  9. VEGA AD, DeRonde K, Jimenez A, Piazza M, et al
    Difficult-to-treat (DTR) Pseudomonas aeruginosa harboring Verona-Integron metallo-beta-lactamase (bla(VIM)): infection management and molecular analysis.
    Antimicrob Agents Chemother. 2024;68:e0147423.
    PubMed         Abstract available

  10. SCHALKWIJK HH, Shewakramani NR, Das K, Andrei G, et al
    Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1.
    Antimicrob Agents Chemother. 2024;68:e0011024.
    PubMed         Abstract available

  11. NIELSEN TK, Petersen IB, Xu L, Barbuti MD, et al
    The Spx stress regulator confers high-level beta-lactam resistance and decreases susceptibility to last-line antibiotics in methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2024 May 1:e0033524. doi: 10.1128/aac.00335.
    PubMed         Abstract available

    Int J Antimicrob Agents

  12. ZHUANG H, Chen M, Hu D, Liu L, et al
    Role of tcaA, a potential target as a ceftobiprole resistance breaker, in MRSA beta-lactam resistance.
    Int J Antimicrob Agents. 2024 Apr 29:107185.
    PubMed         Abstract available

  13. RUSSO A, Gulli SP, D'Avino A, Borrazzo C, et al
    Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a multicenter clinical experience.
    Int J Antimicrob Agents. 2024 Apr 30:107190.
    PubMed         Abstract available

  14. AMODIO E, Pizzo S, Vella G, De Francisci V, et al
    Increase of multidrug-resistant bacteria after the COVID-19 pandemic in a major teaching Hospital in Sicily (2018-2021).
    Int J Antimicrob Agents. 2024;63:107123.
    PubMed         Abstract available

  15. HSU CK, Lai CC, Chen CC, Chen HJ, et al
    Evaluation of three brands of Mueller-Hinton media for broth microdilution method to determine the susceptibility of multidrug-resistant Gram-negative bacilli against eravacycline.
    Int J Antimicrob Agents. 2024;63:107117.

  16. WANG L, Zhou X, Lu Y, Zhang X, et al
    Levofloxacin-induced MexS mutation triggers imipenem-relebactam resistance in a KPC-producing Pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2024;63:107119.
    PubMed         Abstract available

  17. ATHANASSA Z, Manioudaki S, Petsa I, Koumaki V, et al
    Effectiveness and safety of minocycline combination therapy for the treatment of patients with ventilator-associated pneumonia due to extensively drug- or pandrug-resistant Acinetobacter baumannii.
    Int J Antimicrob Agents. 2024;63:107129.

  18. MEZCORD V, Traglia GM, Pasteran F, Escalante J, et al
    Characterisation of cefiderocol-resistant spontaneous mutant variants of Klebsiella pneumoniae-producing NDM-5 with a single mutation in cirA.
    Int J Antimicrob Agents. 2024;63:107131.

  19. MESCHIARI M, Faltoni M, Kaleci S, Tassoni G, et al
    Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience.
    Int J Antimicrob Agents. 2024;63:107134.
    PubMed         Abstract available

  20. LONG H, Zhao F, Feng Y, Zong Z, et al
    Global distribution of bla(CMY-42), a gene mediating reduced susceptibility to aztreonam-avibactam and ceftazidime-avibactam, in Escherichia coli.
    Int J Antimicrob Agents. 2024;63:107141.

  21. MONTE DFM, de Oliveira CJB
    Silent dissemination of fosfomycin resistance genes in critical-priority Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2024;63:107139.

  22. XU H, Tan C, Li C, Li J, et al
    ESBL-Escherichia coli extracellular vesicles mediate bacterial resistance to beta-lactam and mediate horizontal transfer of bla(CTX-M-55).
    Int J Antimicrob Agents. 2024;63:107145.
    PubMed         Abstract available

  23. LIM C, Coombs GW, Daley DA, Shoby P, et al
    Whole-genome sequencing identifies MprF mutations in a genetically diverse population of daptomycin non-susceptible Staphylococcus aureus in Australia.
    Int J Antimicrob Agents. 2024;63:107144.
    PubMed         Abstract available

  24. YANG W, Tang C, Shen S, Shi Q, et al
    Spread and evolution of bla(KPC)-plasmid between Serratia marcescens and Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2024;63:107149.
    PubMed         Abstract available

  25. DE OLIVEIRA HC, Santos MDM, Camillo-Andrade AC, Castelli RF, et al
    Proteomics reveals that the antifungal activity of fenbendazole against Cryptococcus neoformans requires protein kinases.
    Int J Antimicrob Agents. 2024;63:107157.
    PubMed         Abstract available

    J Antimicrob Chemother

  26. ATAMNA A, Yeshurun M, Shargian L, Raanani P, et al
    Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations.
    J Antimicrob Chemother. 2024 Feb 9:dkae038. doi: 10.1093.

  27. UNEMO M, Golparian D, Oxelbark J, Kong FYS, et al
    Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
    J Antimicrob Chemother. 2024;79:1006-1013.
    PubMed         Abstract available

  28. MALLART E, Guerin F, Amoura A, Le Scouarnec M, et al
    Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model.
    J Antimicrob Chemother. 2024;79:1051-1059.
    PubMed         Abstract available

  29. GALANI I, Souli M, Katsala D, Karaiskos I, et al
    In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece.
    J Antimicrob Chemother. 2024;79:1101-1108.
    PubMed         Abstract available

  30. TESSIER E, Ruffier d'Epenoux L, Lartigue MF, Chaufour L, et al
    Comparison of the in vitro activities of delafloxacin and comparators against Staphylococcus epidermidis clinical strains involved in osteoarticular infections: a CRIOGO multicentre retrospective study.
    J Antimicrob Chemother. 2024 Mar 20:dkae071. doi: 10.1093.
    PubMed         Abstract available

  31. AGHOKENG AF, Ngo-Giang-Huong N, Huynh THK, Dagnra AY, et al
    Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries.
    J Antimicrob Chemother. 2024;79:1164-1168.
    PubMed         Abstract available

  32. CHEN GJ, Cheng CY, Yang CJ, Lee NY, et al
    Trends of pre-treatment drug resistance in antiretroviral-naive people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
    J Antimicrob Chemother. 2024;79:1157-1163.
    PubMed         Abstract available

  33. PANG X, He Q, Tang K, Huang J, et al
    Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.
    J Antimicrob Chemother. 2024;79:1142-1152.
    PubMed         Abstract available

  34. BUZON-MARTIN L, Navarro-San Francisco C, Fernandez-Regueras M, Sanchez-Gomez L, et al
    Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature.
    J Antimicrob Chemother. 2024;79:1153-1156.
    PubMed         Abstract available

    PLoS Genet

  35. NAGARAJAN A, Scoggin K, Gupta J, Aminian M, et al
    Collaborative Cross mice have diverse phenotypic responses to infection with Methicillin-resistant Staphylococcus aureus USA300.
    PLoS Genet. 2024;20:e1011229.
    PubMed         Abstract available

    PLoS One

  36. SHEN X, Zhu X, Liu H, Yuan R, et al
    Leveraging genomic signatures of oral microbiome-associated antibiotic resistance genes for diagnosing pancreatic cancer.
    PLoS One. 2024;19:e0302361.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.